Monitoring of reduction of 17-1A-expressing breast cancer micrometastases during antibody therapy with edrecolomab - a pilot study - Braun,S.; Janni,W.; Hepp,F.; Schindlbeck,C.; Sommer,H. (Proc ASCO, 1999)